Please try another search
Frontage Holdings Corporation is a holding company. The principal activities of the Company and its subsidiaries are to provide laboratory and related services to pharmaceutical and agrochemical companies. The Company is a contract research organization (CRO) providing integrated, science-driven, product development services throughout the drug discovery and development process to enable life science companies to achieve their drug development goals. Its segments include North America and the People’s Republic of China (PRC). The North America segment includes laboratory testing, chemistry, manufacturing and control (CMC), preclinical research, early stage clinical/bioequivalence and chemistry services in the USA and Canada. PRC segments include laboratory testing, CMC, preclinical research, early stage clinical/ bioequivalence and chemistry services in the PRC. Its preclinical research services consist of drug metabolism and pharmacokinetic (DMPK) and safety and toxicology.
Name | Age | Since | Title |
---|---|---|---|
Jingsong Wang | 58 | 2018 | Independent Non-Executive Director |
Song Li | 66 | 2014 | Founder & Chairman |
Yifan Li | 56 | 2018 | Independent Non Executive Director |
Zhihe Li | 68 | 2018 | Non-Executive Director |
Erh Fei Liu | 64 | 2018 | Independent Non-Executive Director |
Zhuan Yin | 58 | 2022 | Non-Executive Director |
Hao Wu | 56 | 2022 | Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review